Metabolic
Cagrilintide
AM833 / Long-acting amylin analog
- Peptide length
- 37 amino acids
Long-acting acylated peptide analog
Research contextHuman studies exist
Read the linked studies for their methods and limitations.
A long-acting amylin analog studied for weight management, both alone and in combination with semaglutide.
- Family
- Amylin analog
- Research frame
- Amylin and calcitonin receptor family
- Molecular format
- Long-acting acylated peptide analog
Read the evidence
The monotherapy trial and CagriSema combination trial answer different questions. Combination results cannot be assigned to cagrilintide alone.
Resolve the identity
Cagrilintide is an amylin analog. It should not be classified as a GLP-1 receptor agonist or equated with CagriSema.